logo
SBC Medical Group Acquires MB Career Lounge: 'JUN CLINIC' Joins the Group, Strengthening Competitive Position in a Growing Market

SBC Medical Group Acquires MB Career Lounge: 'JUN CLINIC' Joins the Group, Strengthening Competitive Position in a Growing Market

Business Wire17-07-2025
IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ('SBC Medical' or the 'Company'), a global franchise and provider of services for aesthetic clinics, announced that, on July 17, 2025, it acquired MB career lounge, Co., Ltd. ('MB career lounge'), a privately-held provider of management support services for medical institutions, specializing in consulting, training, and human resources solutions in Japan, through a share purchase transaction for cash consideration.
Through this transaction, JUN CLINIC, operated by Medical Corporation Misakikai and supported by MB career lounge, will join SBC Medical's clinic network, contributing to portfolio diversification and is expected to enhance revenue stability.
'The surging demand for personalized aesthetic solutions, particularly 'Customized Laser Treatment,' underscores a rapidly expanding market. JUN CLINIC's proven success in diverse environments, from the developing regional market of Nagano to the highly competitive urban centers of Ginza and Shirokane, demonstrates a robust and easily scalable business model poised for nationwide expansion. By combining our strengths with MB career lounge and JUN CLINIC, we will strengthen our portfolio of aesthetic dermatology and plastic surgery services, enhancing our ability to serve our customers more effectively and further positioning the Company to capitalize on the growing demand for high-quality aesthetic medical services,' said Yoshiyuki Aikawa, Founder and Chief Executive Officer of SBC Medical. 'This acquisition marks another important step in our growth strategy, accelerating regional expansion, diversifying service offerings, and reinforcing our commitment to driving long-term shareholder value. We look forward to welcoming the MB career lounge and JUN CLINIC team and working together to drive continued success.'
Japan's aesthetic medicine market reached ¥631 billion in 2024, representing year-over-year growth of 6.2%, and is expected to continue its steady expansion.* Against this backdrop, SBC Medical is pleased to welcome JUN CLINIC—an established provider of both aesthetic dermatology and plastic surgery services—into its growing clinic network.
JUN CLINIC is a network of clinics across multiple locations, including Shirokane, Ginza, Tama Plaza, Yokohama, and Nagano, serving a diverse customer base across both metropolitan and regional areas. Renowned for its personalized treatment approach, the clinic offers a comprehensive suite of services including laser therapies, injectables, and thread lifts, all tailored to individual skin conditions and administered under the supervision of a board-certified dermatologist.
This acquisition enables SBC Medical to accelerate regional expansion, broaden its customer base and strengthen its business model by reducing reliance on any single procedure or geography. With JUN CLINIC's long-standing reputation and stable revenue base, the acquisition is expected to enhance SBC Medical's financial performance. Looking ahead, SBC Medical will continue to pursue strategic acquisitions and partnerships with high-quality medical institutions to support long-term growth and drive greater corporate value within the healthcare industry.
The addition of this sophisticated treatment platform aligns with SBC Medical's strategy of diversifying its service offerings and expanding its portfolio to embrace the significant trend of personalized medicine. The global demand for customized, non-invasive aesthetic solutions has the potential to achieve meaningful and durable growth. SBC Medical endeavors to capture this high-value market segment, including through integration of JUN CLINIC's proven model and its team of highly skilled professionals—validated by their role as a certified facility for the prestigious Customized Treatment Study Group.
(*Source: Yano Research Institute Ltd., 'Survey on Japan's Aesthetic Medicine Market 2025')
About MB career lounge, Co., Ltd.
MB career lounge, Co., Ltd. is a consulting firm specializing in the aesthetic medical industry. MB career lounge offers a wide range of training and networking programs designed to enhance the knowledge, skills, and career development of doctors, nurses, and clinic managers. In addition to educational initiatives, MB career lounge provides comprehensive consulting services, including support for clinic startups, marketing strategies, operational optimization, management structure development, and selection and implementation of aesthetic medical devices. MB career lounge also provides management support for JUN CLINIC, operated by the medical corporation Misakikai. MB career lounge's mission is to help clinics solve management challenges, achieve sustainable growth, and build trusted practices that patients choose. https://mbcareer.jp/ (Japanese only)
Transaction Overview
Transaction Type: Share acquisition with cash consideration
Closing Date: July 17, 2025
Consolidation Date: Q3 2025
Funding Source: Bank loan
About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic's customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics. For more information, visit https://sbc-holdings.com/
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's acquisition of MB career lounge, product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as 'may,' 'should,' 'expects,' 'anticipates,' 'contemplates,' 'estimates,' 'believes,' 'plans,' 'projected,' 'predicts,' 'potential,' 'targets' or 'hopes' or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading 'Risk Factors' and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the 'SEC'), which are accessible on the SEC's website at www.sec.gov.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Alibaba (BABA) vs. Amazon (AMZN): Which E-Commerce Stock Has More Upside Ahead of Q2 Earnings?
Alibaba (BABA) vs. Amazon (AMZN): Which E-Commerce Stock Has More Upside Ahead of Q2 Earnings?

Business Insider

time14 minutes ago

  • Business Insider

Alibaba (BABA) vs. Amazon (AMZN): Which E-Commerce Stock Has More Upside Ahead of Q2 Earnings?

The second-quarter earnings season is in full swing, and investors are closely watching global e-commerce leaders like Amazon (AMZN) and Alibaba (BABA) to assess the strength of consumer demand, the outlook for digital retail, and their growing role in artificial intelligence. Using TipRanks' Stock Comparison Tool, we will compare these two tech-powerhouse stocks to find the better pick ahead of the upcoming earnings results, according to Wall Street analysts. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Alibaba (NYSE:BABA) Stock Alibaba is China's largest e-commerce and cloud services company, operating platforms like Taobao, Tmall, and AliCloud. The stock has climbed over 39% so far this year, driven by strong gains in its AI-powered cloud services and growing demand for instant delivery. The company is doubling down on artificial intelligence, aiming to use it to transform online shopping and cloud services. It is using AI across its apps and cloud platform to improve customer experience and stay ahead of the competition. Looking ahead, the company is set to report its Q1 FY26 earnings next month. Wall Street expects Alibaba to report earnings of $2.22 per share for Q1, down 3% from the year-ago quarter. The decline could be due to the company's heavy investment in logistics and delivery. Meanwhile, analysts project Q1 revenues at $35.46 billion, up 6% year-over-year. Is Alibaba Stock a Good Buy Right Now? Ahead of the Q1 results, Benchmark's Top analyst Fawne Jiang reiterated her Buy rating with a $176 price target, implying a 47% gain from current levels. The analyst sees recent share weakness as a 'buying opportunity' and encourages investors to 'build exposure on dips,' confident in Alibaba's strong long-term growth outlook. Nevertheless, she expects Alibaba's margins and profits to come under pressure in the near term due to increased spending. As a result, Benchmark has cut its EBITDA forecast to RMB44 billion for Q1 FY26 and RMB208 billion for the full FY26, 'reflecting near-term margin pressure.' Overall, Wall Street has a Strong Buy consensus rating on Alibaba stock based on 14 Buys and one Hold rating. The average Alibaba price target of $151.08 implies about 26% upside potential from current levels. Amazon (NASDAQ:AMZN) Stock E-commerce and cloud computing giant Amazon is proving the resilience of its business model despite macro challenges and tariff woes. The stock has climbed over 5% so far this year. Several analysts remain bullish on Amazon's high-margin cloud unit, Amazon Web Services (AWS), which is expected to benefit from growing AI demand. In Q1 2025, AWS accounted for just 19% of revenue but delivered an impressive 63% of total operating profit. Meanwhile, Amazon's fast-expanding advertising segment is also emerging as a key growth engine. Looking ahead, Amazon is scheduled to announce its second-quarter results on July 31. Wall Street projects a 9% growth in Amazon's revenue to $162 million. Meanwhile, analysts expect the company to report earnings per share of $1.32 compared to $1.26 in the prior-year quarter. Is Amazon a Buy, Hold, or Sell? Ahead of the Q2 print, BofA Securities analyst Justin Post raised his price target to $265, up from $248, while maintaining a Buy rating. Post expects Amazon's Q2 retail performance to be strong, helped by positive credit card spending data and an extended Prime Day. He also believes AWS is picking up pace, with a strong order backlog and rising cloud demand. The analyst now predicts Q2 revenue of $164 billion, above Wall Street's estimate of $162.1 billion. Turning to Wall Street, AMZN stock has a Strong Buy consensus rating based on 44 Buys and one Hold assigned in the last three months. At $258.27, the average Amazon stock price target implies an 11.59% upside potential. Conclusion Ahead of earnings, Wall Street remains bullish on both Alibaba and Amazon stocks. However, analysts see greater upside potential in Alibaba, supported by its strong fundamentals, expanding AI initiatives, and solid recovery in e-commerce business. Meanwhile, Amazon is gaining from steady growth in cloud and advertising, two high-margin areas set to benefit from AI. While its upside may be smaller than Alibaba's, Amazon's stable growth and strong cash flow continue to earn Wall Street's confidence.

NVIDIA Corporation (NVDA)'s CEO Has A Great Relationship With Trump, Says Jim Cramer
NVIDIA Corporation (NVDA)'s CEO Has A Great Relationship With Trump, Says Jim Cramer

Yahoo

time30 minutes ago

  • Yahoo

NVIDIA Corporation (NVDA)'s CEO Has A Great Relationship With Trump, Says Jim Cramer

We recently published . NVIDIA Corporation (NASDAQ:NVDA) is one of the stocks Jim Cramer recently discussed. After bleeding close to $600 billion in market value in January amidst the DeepSeek selloff, Wall Street's AI chip darling, NVIDIA Corporation (NASDAQ:NVDA) is once again the most valuable company in the world. The firm has benefited from growing investor bullishness about the long-term prospects of AI. NVIDIA Corporation (NASDAQ:NVDA)'s shares closed the week 1% higher after big tech's continued persistence to spend billions of dollars to buy AI chips. Cramer discussed the impact and the CEO's relationship with President Trump: 'All CapEx go up, it's all NVIDIA. . .it's really good for NVIDIA. But of course, NVIDIA, the President talking about breaking them up, we'll get to that later. It was an out of body comment. Previously, the CNBC TV host commented on NVIDIA Corporation (NASDAQ:NVDA)'s shares and parabolic moves: 'What is the solution to this? Look, in my forthcoming book, How to Make Money in Any Market, I have banished my antiparabola bias. I have a method I reveal of picking five stocks to go alongside an index fund with some money added each month. I state point blank that if you are in your 30s or older, you should own one speculative situation like an Oklo, okay, or a Joby. Just one. It could fail you after going parabolic. Moreover, if you're under 30, you can pick two speculative names out of five because you've got enough time to make back any potential losses. Photo by Javier Esteban on Unsplash Now, you may think I'm reckless for endorsing any of these even with caveats, but it's time to admit that for many years now, speculative stocks with great growth, they've worked. Oh, and let's not forget, they don't have to stay speculative. NVIDIA stock has had many parabolic moves, including the one that started in April. To keep yourself out of these runs because of a principle that stopped working ages ago, that's to be blind to change, and I don't like it. I don't want to be that way.' While we acknowledge the potential of NVDA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Alphabet Inc. (GOOGL): 'This Stock Should Be Up Much More,' Says Jim Cramer
Alphabet Inc. (GOOGL): 'This Stock Should Be Up Much More,' Says Jim Cramer

Yahoo

timean hour ago

  • Yahoo

Alphabet Inc. (GOOGL): 'This Stock Should Be Up Much More,' Says Jim Cramer

We recently published . Alphabet Inc. (NASDAQ:GOOGL) is one of the stocks Jim Cramer recently discussed. Cramer regularly discussed tech mega-cap Alphabet Inc. (NASDAQ:GOOGL) ahead of its earnings. The firm's shares have reversed course in July and are up by 1.9% year-to-date, primarily due to July's 9.9% gain. Before the report, Cramer was explicit in sharing that he regretted selling Alphabet Inc. (NASDAQ:GOOGL)'s stock. This time, he discussed the firm's businesses and shared that the stock should be higher after the earnings: [GOOGL]'[On earnings report] Yeah, look cloud was important. I think the big focus is frankly, uh, that paid clicks picked up 4%. I mean I was thinking paid clips might be down, I was worried that I felt that this was the beginning of the erosion and the cannibalization versus Gemini. That was completely wrong. YouTube up 200 million. Really, really fantastic. . . .Look the story here is this that the more chips that they get, better they're doing. They have so much demand I was quite surprised. 20 New Technology Trends for 2024 'This stock should be up much more than that. While we acknowledge the potential of GOOGL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store